CD84 is a regulator of the immunosuppressive microenvironment in multiple myelomaHadas Lewinsky, Idit Shachar, Ting-Fang He et al.|JCI Insight|2021Cited by 64
HDAC inhibitor AR-42 decreases CD44 expression and sensitizes myeloma cells to lenalidomideAlessandro Canella, Flavia Pichiorri|Oncotarget|2015Cited by 43
Daratumumab induces mechanisms of immune activation through CD38+ NK cell targetingDomenico Viola, Flavia Pichiorri|bioRxiv (Cold Spring Harbor Laboratory)|2019Cited by 9
CD84 is a regulator of the immunosuppressive microenvironment in multiple myelomaHadas Lewinsky, Idit Shachar, Emine Gulsen Gunes et al.|JCI Insight|2023Cited by 6